Uncategorized
Mati Therapeutics Announces Purchase of Rights From Novelion Therapeutics Inc.
AUSTIN, Texas--(BUSINESS WIRE)--Mati Therapeutics Inc. (“Mati”) announced that it has purchased all rights related to Mati’s Evolute Punctal Plug Delivery System (PPDS) from Novelion Therapeutics Inc. (“Novelion”). This purchase is part of Novelion’s voluntary liquidation process. Mati previously acquired the intellectual property and other assets comprising the PPDS from Novelion (formerly QLT Inc.) in April 2013. As part of the purchase agreement, Mati was obligated to potentially pay Novelio